Puretech Health PLC (LON:PRTC) insider Robert Langer purchased 4,300 shares of the business’s stock in a transaction dated Tuesday, March 13th. The shares were purchased at an average cost of GBX 162 ($2.24) per share, with a total value of £6,966 ($9,624.21).

Puretech Health PLC (LON PRTC) opened at GBX 164.30 ($2.27) on Wednesday. The company has a market cap of $388.58 and a P/E ratio of -864.74. Puretech Health PLC has a 52 week low of GBX 110 ($1.52) and a 52 week high of GBX 183.50 ($2.54).

How to Become a New Pot Stock Millionaire

PRTC has been the subject of a number of recent analyst reports. Peel Hunt upped their price target on shares of Puretech Health from GBX 302 ($4.17) to GBX 313 ($4.32) and gave the stock a “buy” rating in a report on Friday, January 26th. Jefferies Group reissued a “buy” rating on shares of Puretech Health in a research note on Friday, November 17th. Liberum Capital reissued a “buy” rating and issued a GBX 248 ($3.43) price objective on shares of Puretech Health in a research note on Friday, January 26th. Finally, Numis Securities reissued a “buy” rating and issued a GBX 259 ($3.58) price objective on shares of Puretech Health in a research note on Tuesday, February 20th. Five investment analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and a consensus target price of GBX 260.20 ($3.59).

COPYRIGHT VIOLATION WARNING: This article was first published by Daily Political and is owned by of Daily Political. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this article can be viewed at https://www.dailypolitical.com/2018/03/14/robert-langer-buys-4300-shares-of-puretech-health-plc-prtc-stock.html.

About Puretech Health

PureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets.

Receive News & Ratings for Puretech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Puretech Health and related companies with MarketBeat.com's FREE daily email newsletter.